Matsui Connie - Net Worth and Insider Trading

Matsui Connie Net Worth

The estimated net worth of Matsui Connie is at least $15 Million dollars as of 2024-11-13. Matsui Connie is the Director of Halozyme Therapeutics Inc and owns about 181,983 shares of Halozyme Therapeutics Inc (HALO) stock worth over $11 Million. Matsui Connie is the EVP, Corp. Strategy and Comm. of Biogen Inc and owns about 22,571 shares of Biogen Inc (BIIB) stock worth over $4 Million. Matsui Connie is also the Director of Artelo Biosciences Inc and owns about 3,778 shares of Artelo Biosciences Inc (ARTL) stock worth over $4,420. Details can be seen in Matsui Connie's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Matsui Connie has not made any transactions after 2021-11-05 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Matsui Connie

To

Matsui Connie Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Matsui Connie owns 4 companies in total, including Halozyme Therapeutics Inc (HALO) , Sutro Biopharma Inc (STRO) , and Artelo Biosciences Inc (ARTL) among others .

Click here to see the complete history of Matsui Connie’s form 4 insider trades.

Insider Ownership Summary of Matsui Connie

Ticker Comapny Transaction Date Type of Owner
HALO Halozyme Therapeutics Inc 2021-11-05 director
STRO Sutro Biopharma Inc 2019-06-24 director
ARTL Artelo Biosciences Inc 2020-05-04 director
LIMIT LIMIT 2007-01-16 EVP - Corp Comm & Strategy

Matsui Connie Latest Holdings Summary

Matsui Connie currently owns a total of 3 stocks. Among these stocks, Matsui Connie owns 181,983 shares of Halozyme Therapeutics Inc (HALO) as of November 5, 2021, with a value of $11 Million and a weighting of 74.05%. Matsui Connie owns 22,571 shares of Biogen Inc (BIIB) as of January 16, 2007, with a value of $4 Million and a weighting of 25.92%. Matsui Connie also owns 3,778 shares of Artelo Biosciences Inc (ARTL) as of May 4, 2020, with a value of $4,420 and a weighting of 0.03%.

Latest Holdings of Matsui Connie

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
HALO Halozyme Therapeutics Inc 2021-11-05 181,983 59.64 10,853,466
BIIB Biogen Inc 2007-01-16 22,571 168.28 3,798,248
ARTL Artelo Biosciences Inc 2020-05-04 3,778 1.17 4,420

Holding Weightings of Matsui Connie


Matsui Connie Form 4 Trading Tracker

According to the SEC Form 4 filings, Matsui Connie has made a total of 2 transactions in Halozyme Therapeutics Inc (HALO) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in Halozyme Therapeutics Inc is the sale of 32,000 shares on November 5, 2021, which brought Matsui Connie around $1 Million.

According to the SEC Form 4 filings, Matsui Connie has made a total of 0 transactions in Biogen Inc (BIIB) over the past 5 years. The most-recent trade in Biogen Inc is the sale of 24,823 shares on January 16, 2007, which brought Matsui Connie around $1 Million.

According to the SEC Form 4 filings, Matsui Connie has made a total of 1 transactions in Artelo Biosciences Inc (ARTL) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Artelo Biosciences Inc is the acquisition of 2,778 shares on May 4, 2020, which cost Matsui Connie around $50,000.

Insider Trading History of Matsui Connie

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Matsui Connie Trading Performance

GuruFocus tracks the stock performance after each of Matsui Connie's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Matsui Connie is -7.88%. GuruFocus also compares Matsui Connie's trading performance to market benchmark return within the same time period. The performance of stocks bought by Matsui Connie within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Matsui Connie's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Matsui Connie

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
1 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -0.8 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) -10.28 LIMIT LIMIT LIMIT LIMIT LIMIT

Matsui Connie Ownership Network

Ownership Network List of Matsui Connie

No Data

Ownership Network Relation of Matsui Connie

Insider Network Chart

Matsui Connie Owned Company Details

What does Halozyme Therapeutics Inc do?

Who are the key executives at Halozyme Therapeutics Inc?

Matsui Connie is the director of Halozyme Therapeutics Inc. Other key executives at Halozyme Therapeutics Inc include SVP & Chief Technical Officer Michael J. Labarre , director & President and CEO Helen Torley , and SVP & Chief Financial Officer Nicole Labrosse .

Halozyme Therapeutics Inc (HALO) Insider Trades Summary

Over the past 18 months, Matsui Connie made no insider transaction in Halozyme Therapeutics Inc (HALO). Other recent insider transactions involving Halozyme Therapeutics Inc (HALO) include a net sale of 280,000 shares made by Michael J. Labarre , a net sale of 200,000 shares made by Helen Torley , and a net sale of 49,881 shares made by Matthew L. Posard .

In summary, during the past 3 months, insiders sold 199,881 shares of Halozyme Therapeutics Inc (HALO) in total and bought 0 shares, with a net sale of 199,881 shares. During the past 18 months, 584,881 shares of Halozyme Therapeutics Inc (HALO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 584,881 shares.

Halozyme Therapeutics Inc (HALO)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Halozyme Therapeutics Inc Insider Transactions

No Available Data

Matsui Connie Mailing Address

Above is the net worth, insider trading, and ownership report for Matsui Connie. You might contact Matsui Connie via mailing address: 3030 Callan Rd, San Diego Ca 92121.